Investment Review Report
비앤비코리아
Business Reg. No. 1308660341 · CEO 함봉춘
I.Investment Overview
| Target | 비앤비코리아 (1308660341) |
| Investment | — |
| Post-deal stake | — |
| Valuation | Pre — / Post — |
II.Investment Highlights
No investment highlights written yet.
III.Investment Risks
No risks written yet.
IV.Company Profile
| 회사명 | 비앤비코리아 |
| 영문명 | B&B Korea Co., Ltd. |
| 대표자 | 함봉춘 |
| 사업자등록번호 | 1308660341 |
| 법인등록번호 | 1211110217638 |
| 설립일 | 2011.05.06 |
V.Financial Summary
Per DART disclosure · in 억/만원 (KRW)
Financial trend (100M KRW)
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| 자산총계 | 710.1억원 | 452.3억원 | 343.6억원 | 202.1억원 | 158.7억원 |
| 부채총계 | 251.3억원 | 104.8억원 | 185.3억원 | 149.8억원 | 158.3억원 |
| 자본총계 | 458.8억원 | 347.5억원 | 158.2억원 | 52.4억원 | 4,665만원 |
| 매출액 | 1,358.5억원 | — | — | — | — |
| 영업이익 | 240.4억원 | — | — | — | — |
| 순이익 | 231.6억원 | — | — | — | — |
VI.Financial Ratios
FY2025 basis
17.69%
영업이익률
17.05%
순이익률
32.61%
ROA
50.47%
ROE
54.77%
부채비율
64.61%
자기자본비율
VII.R&D Activity
Fields 생명과학 > 산업바이오
Keywords 발효, 화장품, 요거트, 아미노산, 유산균
| Year | Projects | Papers | Patents |
|---|---|---|---|
| 2019 | 0 | 0 | 2 |
| 2018 | 0 | 0 | 4 |
| 2017 | 1 | 0 | 4 |
| 2016 | 1 | 0 | 0 |
| 2015 | 1 | 0 | 0 |
VIII.Valuation & Exit Plan
| Exit valuation | — |
| Holding period | 5y |
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.
This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.